|
1
|
Schakman O, Kalista S, Barbé C, Loumaye A
and Thissen JP: Glucocorticoid-induced skeletal muscle atrophy. Int
J Biochem Cell Biol. 45:2163–2172. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rhen T and Cidlowski JA: Antiinflammatory
action of glucocorticoids-new mechanisms for old drugs. N Engl J
Med. 353:1711–1723. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rauch A, Seitz S, Baschant U, Schilling
AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A,
Schmidt-Ullrich R, et al: Glucocorticoids suppress bone formation
by attenuating osteoblast differentiation via the monomeric
glucocorticoid receptor. Cell Metab. 11:517–531. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ma K, Mallidis C, Bhasin S, Mahabadi V,
Artaza J, Gonzalez-Cadavid N, Arias J and Salehian B:
Glucocorticoid-induced skeletal muscle atrophy is associated with
upregulation of myostatin gene expression. Am J Physiol Endocrinol
Metab. 285:E363–E371. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Waddell DS, Baehr LM, van den Brandt J,
Johnsen SA, Reichardt HM, Furlow JD and Bodine SC: The
glucocorticoid receptor and FOXO1 synergistically activate the
skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol
Endocrinol Metab. 295:E785–E797. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Braun TP, Szumowski M, Levasseur PR,
Grossberg AJ, Zhu X, Agarwal A and Marks DL: Muscle atrophy in
response to cytotoxic chemotherapy is dependent on intact
glucocorticoid signaling in skeletal muscle. PLoS One.
9(e106489)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Braun TP and Marks DL: The regulation of
muscle mass by endogenous glucocorticoids. Front Physiol.
6(12)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shimizu N, Yoshikawa N, Ito N, Maruyama T,
Suzuki Y, Takeda S, Nakae J, Tagata Y, Nishitani S, Takehana K, et
al: Crosstalk between glucocorticoid receptor and nutritional
sensor mTOR in skeletal muscle. Cell Metab. 13:170–182.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bodine SC and Furlow JD: Glucocorticoids
and skeletal muscle. Adv Exp Med Biol. 872:145–176. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schakman O, Gilson H, Kalista S and
Thissen JP: Mechanisms of muscle atrophy induced by
glucocorticoids. Horm Res. 72 (Suppl 1):S36–S41. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao SQ, Xu SQ, Cheng J, Cao XL, Zhang Y,
Zhou WP, Huang YJ, Wang J and Hu XM: Anti-inflammatory effect of
external use of escin on cutaneous inflammation: Possible
involvement of glucocorticoids receptor. Chin J Nat Med.
16:105–112. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zheng B, Ohkawa S, Li H, Roberts-Wilson TK
and Price SR: FOXO3a mediates signaling crosstalk that coordinates
ubiquitin and atrogin-1/MAFbx expression during
glucocorticoid-induced skeletal muscle atrophy. FASEB J.
24:2660–2669. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Watson ML, Baehr LM, Reichardt HM,
Tuckermann JP, Bodine SC and Furlow JD: A cell-autonomous role for
the glucocorticoid receptor in skeletal muscle atrophy induced by
systemic glucocorticoid exposure. Am J Physiol Endocrinol Metab.
302:E1210–E1220. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bodine SC, Latres E, Baumhueter S, Lai VK,
Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K,
et al: Identification of ubiquitin ligases required for skeletal
muscle atrophy. Science. 294:1704–1708. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stitt TN, Drujan D, Clarke BA, Panaro F,
Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD and Glass DJ: The
IGF-1/PI3K/Akt pathway prevents expression of muscle
atrophy-induced ubiquitin ligases by inhibiting FOXO transcription
factors. Mol Cell. 14:395–403. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li J, Chan MC, Yu Y, Bei Y, Chen P, Zhou
Q, Cheng L, Chen L, Ziegler O, Rowe GC, et al: miR-29b contributes
to multiple types of muscle atrophy. Nat Commun.
8(15201)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Horak M, Novak J and Bienertova-Vasku J:
Muscle-specific microRNAs in skeletal muscle development. Dev Biol.
410:1–13. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen JF, Mandel EM, Thomson JM, Wu Q,
Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
McCarthy JJ and Esser KA: MicroRNA-1 and
microRNA-133a expression are decreased during skeletal muscle
hypertrophy. J Appl Physiol (1985). 102:306–313. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Soares RJ, Cagnin S, Chemello F,
Silvestrin M, Musaro A, De Pitta C, Lanfranchi G and Sandri M:
Involvement of microRNAs in the regulation of muscle wasting during
catabolic conditions. J Biol Chem. 289:21909–21925. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Walden TB, Timmons JA, Keller P,
Nedergaard J and Cannon B: Distinct expression of muscle-specific
microRNAs (myomirs) in brown adipocytes. J Cell Physiol.
218:444–449. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ivey KN and Srivastava D: microRNAs as
developmental regulators. Cold Spring Harb Perspect Biol.
7(a008144)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lei Z, Sluijter JP and van Mil A: MicroRNA
therapeutics for cardiac regeneration. Mini Rev Med Chem.
15:441–451. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shen H, Liu T, Fu L, Zhao S, Fan B, Cao J
and Li X: Identification of microRNAs involved in
dexamethasone-induced muscle atrophy. Mol Cell Biochem.
381:105–113. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Militello G, Hosen MR, Ponomareva Y,
Gellert P, Weirick T, John D, Hindi SM, Mamchaoui K, Mouly V,
Döring C, et al: A novel long non-coding RNA myolinc regulates
myogenesis through TDP-43 and Filip1. J Mol Cell Biol. 10:102–117.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xiong W, Jiang YX, Ai YQ, Liu S, Wu XR,
Cui JG, Qin JY, Liu Y, Xia YX, Ju YH, et al: Microarray analysis of
long non-coding RNA expression profile associated with
5-fluorouracil-based chemoradiation resistance in colorectal cancer
cells. Asian Pac J Cancer Prev. 16:3395–3402. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen R, Jiang T, She Y, Xie S, Zhou S, Li
C, Ou J and Liu Y: Comprehensive analysis of lncRNAs and mRNAs with
associated co-expression and ceRNA networks in C2C12 myoblasts and
myotubes. Gene. 647:164–173. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Boltaña S, Valenzuela-Miranda D, Aguilar
A, Mackenzie S and Gallardo-Escárate C: Long noncoding RNAs
(lncRNAs) dynamics evidence immunomodulation during ISAV-Infected
Atlantic salmon (Salmo salar). Sci Rep. 6(22698)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun L, Si M, Liu X, Choi JM, Wang Y,
Thomas SS, Peng H and Hu Z: Long-noncoding RNA Atrolnc-1 promotes
muscle wasting in mice with chronic kidney disease. J Cachexia
Sarcopenia Muscle. 9:962–974. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Y, Meng X, Li G, Zhou Q and Xiao J:
Noncoding RNAs in muscle atrophy. Adv Exp Med Biol. 1088:249–266.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang ZK, Li J, Guan D, Liang C, Zhuo Z,
Liu J, Lu A, Zhang G and Zhang BT: Long noncoding RNA lncMUMA
reverses established skeletal muscle atrophy following mechanical
unloading. Mol Ther. 26:2669–2680. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Legnini I, Morlando M, Mangiavacchi A,
Fatica A and Bozzoni I: A feedforward regulatory loop between HuR
and the long noncoding RNA linc-MD1 controls early phases of
myogenesis. Mol Cell. 53:506–514. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang L, Zhao Y, Bao X, Zhu X, Kwok YK, Sun
K, Chen X, Huang Y, Jauch R, Esteban MA, et al: LncRNA Dum
interacts with Dnmts to regulate Dppa2 expression during myogenic
differentiation and muscle regeneration. Cell Res. 25:335–350.
2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang ZK, Li J, Guan D, Liang C, Zhuo Z,
Liu J, Lu A, Zhang G and Zhang BT: A newly identified lncRNA MAR1
acts as a miR-487b sponge to promote skeletal muscle
differentiation and regeneration. J Cachexia Sarcopenia Muscle.
9:613–626. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fappi A, Neves JC, Sanches LN, Massaroto
E, Silva PV, Sikusawa GY, Brandão TPC, Chadi G and Zanoteli E:
Skeletal muscle response to deflazacort, dexamethasone and
methylprednisolone. Cells. 8(406)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Troncoso R, Paredes F, Parra V, Gatica D,
Vásquez-Trincado C, Quiroga C, Bravo-Sagua R, López-Crisosto C,
Rodriguez AE, Oyarzún AP, et al: Dexamethasone-induced autophagy
mediates muscle atrophy through mitochondrial clearance. Cell
Cycle. 13:2281–2295. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Becker DE: Basic and clinical pharmacology
of glucocorticosteroids. Anesth Prog. 60:25–32. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Son YH, Jang EJ, Kim YW and Lee JH:
Sulforaphane prevents dexamethasone-induced muscle atrophy via
regulation of the Akt/Foxo1 axis in C2C12 myotubes. Biomed
Pharmacother. 95:1486–1492. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chen R, Jiang T, Lei S, She Y, Shi H, Zhou
S, Ou J and Liu Y: Expression of circular RNAs during C2C12
myoblast differentiation and prediction of coding potential based
on the number of open reading frames and N6-methyladenosine motifs.
Cell Cycle. 17:1832–1845. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Massaccesi L, Goi G, Tringali C, Barassi
A, Venerando B and Papini N: Dexamethasone-induced skeletal muscle
atrophy increases O-GlcNAcylation in C2C12 cells. J Cell Biochem.
117:1833–1842. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Townley-Tilson WD, Callis TE and Wang D:
MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac
muscle development, function, and disease. Int J Biochem Cell Biol.
42:1252–1255. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Amirouche A, Jahnke VE, Lunde JA, Koulmann
N, Freyssenet DG and Jasmin BJ: Muscle-specific microRNA-206
targets multiple components in dystrophic skeletal muscle
representing beneficial adaptations. Am J Physiol Cell Physiol.
312:C209–C221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liu C, Wang M, Chen M, Zhang K, Gu L, Li
Q, Yu Z, Li N and Meng Q: miR-18a induces myotubes atrophy by
down-regulating IgfI. Int J Biochem Cell Biol. 90:145–154.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Antoniou A, Mastroyiannopoulos NP, Uney JB
and Phylactou LA: miR-186 inhibits muscle cell differentiation
through myogenin regulation. J Biol Chem. 289:3923–3935.
2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lei S, She Y, Zeng J, Chen R, Zhou S and
Shi H: Expression patterns of regulatory lncRNAs and miRNAs in
muscular atrophy models induced by starvation in vitro and in vivo.
Mol Med Rep. 20:4175–4185. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mercatelli N, Fittipaldi S, De Paola E,
Dimauro I, Paronetto MP, Jackson MJ and Caporossi D: MiR-23-TrxR1
as a novel molecular axis in skeletal muscle differentiation. Sci
Rep. 7(7219)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hou L, Xu J, Jiao Y, Li H, Pan Z, Duan J,
Gu T, Hu C and Wang C: MiR-27b promotes muscle development by
inhibiting MDFI expression. Cell Physiol Biochem. 46:2271–2283.
2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Oray M, Abu Samra K, Ebrahimiadib N, Meese
H and Foster CS: Long-term side effects of glucocorticoids. Expert
Opin Drug Saf. 15:457–465. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Stout A, Friedly J and Standaert CJ:
Systemic absorption and side effects of locally injected
glucocorticoids. PM R. 11:409–419. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Matsuzaka Y, Kishi S, Aoki Y, Komaki H,
Oya Y, Takeda S and Hashido K: Three novel serum biomarkers, miR-1,
miR-133a, and miR-206 for Limb-girdle muscular dystrophy,
Facioscapulohumeral muscular dystrophy, and becker muscular
dystrophy. Environ Health Prev Med. 19:452–458. 2014.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Li G, Li QS, Li WB, Wei J, Chang WK, Chen
Z, Qiao HY, Jia YW, Tian JH and Liang BS: miRNA targeted signaling
pathway in the early stage of denervated fast and slow muscle
atrophy. Neural Regen Res. 11:1293–1303. 2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Luo W, Chen J, Li L, Ren X, Cheng T, Lu S,
Lawal RA, Nie Q, Zhang X and Hanotte O: c-Myc inhibits myoblast
differentiation and promotes myoblast proliferation and muscle
fibre hypertrophy by regulating the expression of its target genes,
miRNAs and lincRNAs. Cell Death Differ. 26:426–442. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Lin CH, Jackson AL, Guo J, Linsley PS and
Eisenman RN: Myc-regulated microRNAs attenuate embryonic stem cell
differentiation. EMBO J. 28:3157–3170. 2009.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Eischen CM, Packham G, Nip J, Fee BE,
Hiebert SW, Zambetti GP and Cleveland JL: Bcl-2 is an apoptotic
target suppressed by both c-Myc and E2F-1. Oncogene. 20:6983–6993.
2001.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Alessio E, Buson L, Chemello F, Peggion C,
Grespi F, Martini P, Massimino ML, Pacchioni B, Millino C, Romualdi
C, et al: Single cell analysis reveals the involvement of the long
non-coding RNA Pvt1 in the modulation of muscle atrophy and
mitochondrial network. Nucleic Acids Res. 47:1653–1670.
2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
van de Worp WR, Theys J, van Helvoort A
and Langen RC: Regulation of muscle atrophy by microRNAs:
‘AtromiRs’ as potential target in cachexia. Curr Opin Clin Nutr
Metab Care. 21:423–429. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Hildebrandt T, Shope S, Varangis E, Klein
D, Pfaff DW and Yehuda R: Exercise reinforcement, stress, and
β-endorphins: An initial examination of exercise in
anabolic-androgenic steroid dependence. Drug Alcohol Depend.
139:86–92. 2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ng TP, Lu Y, Choo RW, Tan CT, Nyunt MS,
Gao Q, Mok EW and Larbi A: Dysregulated homeostatic pathways in
sarcopenia among frail older adults. Aging Cell.
17(e12842)2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhu M, Liu J, Xiao J, Yang L, Cai M, Shen
H, Chen X, Ma Y, Hu S, Wang Z, et al: Lnc-mg is a long non-coding
RNA that promotes myogenesis. Nat Commun. 8(14718)2017.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Devaux Y, Zangrando J, Schroen B, Creemers
EE, Pedrazzini T, Chang CP, Dorn GW II, Thum T and Heymans S:
Cardiolinc network. Long noncoding RNAs in cardiac development and
ageing. Nat Rev Cardiol. 12:415–425. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cichewicz MA, Kiran M, Przanowska RK,
Sobierajska E, Shibata Y and Dutta A: MUNC, an enhancer RNA
upstream from the MYOD gene, induces a subgroup of myogenic
transcripts in trans independently of MyoD. Mol Cell Biol.
38:e00655–17. 2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mueller AC, Cichewicz MA, Dey BK, Layer R,
Reon BJ, Gagan JR and Dutta A: MUNC, a long noncoding RNA that
facilitates the function of MyoD in skeletal myogenesis. Mol Cell
Biol. 35:498–513. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Li Z, Cai B, Abdalla BA, Zhu X, Zheng M,
Han P, Nie Q and Zhang X: LncIRS1 controls muscle atrophy via
sponging miR-15 family to activate IGF1-PI3K/AKT pathway. J
Cachexia Sarcopenia Muscle. 10:391–410. 2019.PubMed/NCBI View Article : Google Scholar
|
